OTC · Financial Statements

CERo Therapeutics Holdings, Inc. (CERO) Financial Statements

$0.01 OTC: CERO Market Cap $14464

CERo Therapeutics Holdings, Inc. most recently reported annual revenue of $0, net profit of $-20.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$-3.0M$-3.0M$-15.0M$-18.0M
Net Profit$0$-1.0M$0$-8.0M$-20.0M
EPS$-2.75$-19.73$-2497.20$-6.87$-22.58
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$180.0M$42.0M$5.0M$6.0M$4.0M
Total Liabilities$9.0M$40.0M$47.0M$8.0M$9.0M
Cash$1.0M$42.0M$2.0M$3.0M$2.0M
Borrowings$4.0M$1.0M$2.0M$2.0M$1.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$-6.0M$-6.0M$-16.0M
Investing Cash Flow$-179.0M$180.0M$0$0$1.0M
Financing Cash Flow$0$-279.0M$0$-13.0M$0
Net Cash Flow$1.0M$41.0M$-5.0M$-5.0M$-2.0M
Free Cash Flow$-1.0M$-2.0M$-6.0M$-6.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.01
FCF Yield-99527.38%
Quick Ratio0.14
Interest Coverage-110.40
Return 1Y-99.86%
Return 3Y-100.00%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
CERO Overview CERO Dividend Run Stock Screener